Abstract
The treatment of trigeminal neuralgia (HTN) in the elderly, highlighted in the literature, reflects the dissatisfaction of clinicians with the results of the treatment of this chronic disease. Scientific research on the treatment of trigeminal neuralgia in the elderly is carried out by improving drug therapy through the introduction of new drugs and their combinations and through the development of new surgical techniques that affect the trigeminal nerve system (TN). Each of the therapeutic methods is mainly aimed at a single link in the pathogenetic chain of the development of trigeminal neuralgia, either to increase the threshold of excitability of sensitized neurons of the brain stem and cortex or to turn off the trigger zone.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
